This study investigates epithelial ovarian cancer and pancreatic adenocarcinoma. Participants will be involved in a multimodal prehabilitation intervention during chemotherapy.
The study evaluates the effectiveness of prehabilitation in improving physical fitness, functional outcomes, perioperative outcomes, nutritional status, and quality of life compared to standard care.
- Who can participate: Participants aged 65 and older with advanced epithelial ovarian, fallopian tube, or pancreatic adenocarcinoma undergoing neoadjuvant chemotherapy can join. Those with severe cardiopulmonary disease or physical immobility are excluded.
- Study details: Participants will engage in exercise and nutrition programs to prepare for surgery. A placebo will not be used.
How understandable was the trial content above?
Hard to understand
Easy to understand